rs13197301
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000681022.1(AHI1):c.-2303T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.034 in 215,572 control chromosomes in the GnomAD database, including 171 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 114 hom., cov: 32)
Exomes 𝑓: 0.033 ( 57 hom. )
Consequence
AHI1
ENST00000681022.1 5_prime_UTR
ENST00000681022.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.865
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 6-135497787-A-G is Benign according to our data. Variant chr6-135497787-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1186019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0508 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0344 AC: 5225AN: 152088Hom.: 113 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5225
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0300 AC: 131AN: 4366 AF XY: 0.0289 show subpopulations
GnomAD2 exomes
AF:
AC:
131
AN:
4366
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0331 AC: 2100AN: 63366Hom.: 57 Cov.: 0 AF XY: 0.0287 AC XY: 1132AN XY: 39498 show subpopulations
GnomAD4 exome
AF:
AC:
2100
AN:
63366
Hom.:
Cov.:
0
AF XY:
AC XY:
1132
AN XY:
39498
Gnomad4 AFR exome
AF:
AC:
4
AN:
432
Gnomad4 AMR exome
AF:
AC:
17
AN:
1012
Gnomad4 ASJ exome
AF:
AC:
38
AN:
1492
Gnomad4 EAS exome
AF:
AC:
0
AN:
298
Gnomad4 SAS exome
AF:
AC:
156
AN:
20432
Gnomad4 FIN exome
AF:
AC:
205
AN:
4268
Gnomad4 NFE exome
AF:
AC:
1585
AN:
32878
Gnomad4 Remaining exome
AF:
AC:
94
AN:
2370
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0343 AC: 5222AN: 152206Hom.: 114 Cov.: 32 AF XY: 0.0339 AC XY: 2525AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
5222
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
2525
AN XY:
74432
Gnomad4 AFR
AF:
AC:
0.00965288
AN:
0.00965288
Gnomad4 AMR
AF:
AC:
0.0279812
AN:
0.0279812
Gnomad4 ASJ
AF:
AC:
0.02797
AN:
0.02797
Gnomad4 EAS
AF:
AC:
0.000193798
AN:
0.000193798
Gnomad4 SAS
AF:
AC:
0.00890638
AN:
0.00890638
Gnomad4 FIN
AF:
AC:
0.0534603
AN:
0.0534603
Gnomad4 NFE
AF:
AC:
0.0522608
AN:
0.0522608
Gnomad4 OTH
AF:
AC:
0.028828
AN:
0.028828
Heterozygous variant carriers
0
259
519
778
1038
1297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 12, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at